Reviva Pharmaceuticals Holdings Inc (NASDAQ:RVPH) does about 695.41K shares in volume on a normal day but saw 1168700 shares change hands in the recent trading day. The company now has a market cap of 38.12M USD. Its current market price is $0.82, marking a decrease of -7.32% compared to the previous close of $0.88. The 52 week high reached by this stock is $4.28 whilst the lowest price level in 52 weeks is $0.49.
The consensus objective for the share price is $9.00, suggesting that the stock has a potential upside of 90.89% over the period.
FactSet Research has provided data showing that 1 brokerages have issued ratings for the stock. 0 analysts have rated it as a sell, while 0 advise that it is a overweight. 1 analysts have rated it as a buy and 0 have advised that investors hold their positions. The consensus recommendation rating is Buy and Wall Street’s advice is for investors to Strong Buy the stock.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on September 20, 2023 when ROTH MKM initiated the stock to “Buy” and issued a price target of $12. H.C. Wainwright initiated its price target at $10.
The current price level is -9.62%, -2.92%, and -36.27% away from its SMA20, SMA50, and SMA200 respectively, with the RVPH price moving above the 50-day SMA on current market day. Reviva Pharmaceuticals Holdings Inc (RVPH) stock is down -25.85% over the week and -5.92% over the past month. Its price is -54.94% year-to-date and -40.47% over the past year.
To reach the target analysts have set, the stock logically needs to grow 90.89 percent from here.
Outstanding shares total 46.74M with insiders holding 10.58% of the shares and institutional holders owning 20.90% of the company’s common stock. The company has a return on equity of -916.17%. The beta has a value of 0.11.
